The purpose of the Div. 55 Research Council is to promote dissemination of high-quality, evidence-based research related to the causes of and treatments for mental illness and substance use disorders. The task of the council is to keep abreast of the clinical research relevant to the specialty and highlight articles and issues of interest. It encourages the critical reading of research and monitors ongoing trends in clinical psychopharmacology with an informed understanding of the needs of the populations served by psychologists specially trained in clinical psychopharmacology. The Research Council posts relevant recent articles on this website, disseminates relevant information on clinical psychopharmacology to the membership via the Div. 55 listserv, and acts as consultant to Div. 55 and other APA Divisions, and as a potential advisory resource to inform APA policy decisions on matters related to psychologists who have an interest in the application of psychopharmacological principles within their practice or those specially trained psychologists who have or intend to pursue prescription privileges. Finally, the Research Council offers its members’ expertise and knowledge base as speakers on topics related to psychopharmacology and as a resource to SPTA committees in states that are in the process of or contemplating pursuing RxP legislation.
- David M. Latini, PhD, MSW, MSCP
- Alan Lincoln, PhD, MSCP, BCBA-D
- David Shearer, PhD, MSCP
- Andris Skuja, PhD
- Judi Steinman, PhD